Browsing "1. Journal Papers" by Issue Date :

Jump to a point in the index:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 41 to 60 of 3450

This table browses all dspace content
Issue DateTitleJournal Title
2024Histopathologic classification and immunohistochemical features of papillary renal neoplasm with potential therapeutic targets JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE
2024Fine needle aspiration cytology diagnoses of follicular thyroid carcinoma: results from a multicenter study in Asia JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE
2024Incorporating supramaximal resection into survival stratification of IDH-wildtype glioblastoma: a refined multi-institutional recursive partitioning analysisCLINICAL CANCER RESEARCH
2024Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 h+HER2-breast cancer: a retrospective analysis BREAST CANCER RESEARCH
2024Immune environment of high-TIL breast cancer: triple negative and hormone receptor positive HER2 negative NPJ BREAST CANCER
2024Epigenetic and Immune Profile Characteristics in Sinonasal Undifferentiated Carcinoma CANCER MEDICINE
2024Deep learning-driven macroscopic AI segmentation model for brain tumor detection via digital pathology: Foundations for terahertz imaging-based AI diagnostics HELIYON
2024Expression of claudin 18.2 in poorly cohesive carcinoma and its association with clinicopathologic parameters in East Asian patients PATHOLOGY RESEARCH AND PRACTICE
2024Expression of PD-L1 in breast invasive lobular carcinoma PLOS ONE
2024Varlitinib and Paclitaxel for EGFR/HER2 Co-expressing Advanced Gastric Cancer: A Multicenter Phase Ib/II Study (K-MASTER-13) CANCER RESEARCH AND TREATMENT
2024Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial CLINICAL AND MOLECULAR HEPATOLOGY
2024Exploring the Potential of Enhanced Prognostic Performance of NCCN-IPI in Diffuse Large B-Cell Lymphoma by Integrating Tumor Microenvironment Markers: Stromal FOXC1 and Tumor pERK1/2 Expression CANCER MEDICINE
2024Severe acute liver disease in adults: Contemporary role of histopathologyHISTOPATHOLOGY
2024Leptomeningeal metastases in isocitrate dehydrogenase-wildtype glioblastomas revisited: Comprehensive analysis of incidence, risk factors, and prognosis based on post-contrast fluid-attenuated inversion recoveryNEURO-ONCOLOGY
2024Advances in Understanding Hepatocellular Carcinoma Vasculature: Implications for Diagnosis, Prognostication, and Treatment KOREAN JOURNAL OF RADIOLOGY
2024Exploring the Therapeutic Potential of Nicotinamide‐N‐Methyltransferase in Clear Cell Renal Cell Carcinoma Biology and Life Sciences Forum
2024UCHL1 Overexpression Is Related to the Aggressive Phenotype of Non-small Cell Lung Cancer TUBERCULOSIS AND RESPIRATORY DISEASES
2024Restoring H&E stain in faded slides via phase-to-color virtual staining in near-infrared APL PHOTONICS
2024Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as a Potential Biomarker for Immune Checkpoint Inhibitors in Patients with Biliary Tract CancerCLINICAL CANCER RESEARCH
2024Successful eculizumab treatment as an adjunctive therapy to desensitization in ABO-incompatible living donor kidney transplantation and its molecular phenotypes FRONTIERS IN IMMUNOLOGY

Browse

Links